First multicenter study submitted and approved through CTIS Clinical Trials 16 August, 2022 First multicenter study submitted and approved through CTIS The EU-SolidAct study, the purpose of which is to evaluate the safety and effectiveness of therapeutic substances in hospitalized patients diagnosed with COVID 19 through a platform design, is being implemented in the Czech…
Read more

Clinical data management: Senior consultant for CZECRIN as a guest of the IBA podcast Clinical Trials 1 August, 2022 Clinical data management: Senior consultant for CZECRIN as a guest of the IBA podcast Tomáš Machulka, clinical data manager of Premier Research and senior consultant of CZECRIN spoke in the sixth episode of IBA (Institute of…
Read more

CZECRIN representatives visited the AGEL hospital in Třinec Network 28 July, 2022 CZECRIN representatives visited the AGEL hospital in Třinec On Tuesday 19 July 2022, a working meeting between representatives of LRI CZECRIN and the hospital management took place at the AGEL Třinec-Podlesí hospital. The impulse for the meeting was the cardiology conference "CZECRIN Cardionet",…
Read more

ECRIN has published a 2021 report ECRIN 21 July, 2022 ECRIN has published a 2021 report ECRIN has published its report for the year 2021. The annual report has changed its form compared to last years, in connection with the recent change of ECRIN's visual identity. Changing the format to square is then intended to…
Read more

The ISIDORe project opened new calls for research projects on infectious diseases Research 20 July, 2022 The ISIDORe project opened new calls for research projects on infectious diseases In spring 2022, the ISIDORe project was launched, providing an integrated portfolio of cutting-edge research services and resources for the study of pathogens susceptible to epidemics, including…
Read more

CZECRIN Research Annual Conference 2022 was succesfully held Events 12 July, 2022 CZECRIN Research Annual Conference 2022 was succesfully held A month ago, on June 9, 2022, the fourth CZECRIN Annual Scientific Conference 2022 took place. After last year's online meeting, we were finally able to meet in person this year. However, since we saw…
Read more

ECRIN Marketplace is now open to all medical areas! ECRIN 8 July, 2022 ECRIN Marketplace is now open to all medical areas! The ECRIN Marketplace was launched in spring 2021 as a free online platform with an overview of planned or established studies on Covid-19. Its goal was to make it easier to find researchers…
Read more

Head of CZECRIN again as a guest of the Round Tables of the Medical Diary (Zdravotnický deník) Oncology 28 June 2022 Head of CZECRIN again as a guest of the Round Tables of the Medical Diary (Zdravotnický deník) The topic of oncological diseases is becoming more and more important. If there was no COVID-19 pandemic,…
Read more

CT HALF and CZECRIN part of the Olomouc Hematology Days Clinical Trials 21. June 2022 CT HALF and CZECRIN part of the Olomouc Hematology Days On Thursday, May 26, 2022, the first day of Congress XXXIV. Olomouc Hematology Days (https://www.olhemdny.cz/), a meeting of the CELL and the Leukemia Section took place, which included an investigative…
Read more

The course of CT REMED Clinical Trials 13. June 2022 The course of CT REMED The course Recruitment to the REMED study on COVID-19 in serious condition was terminated on March 9, 2022 due to a receding pandemic. The sponsor of this clinical trial is the University Hospital Brno and is implemented in cooperation with…
Read more